Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by T. Ueki
Melphalan 140mg/M2 Combined With TBI2(4)Gy and Fludarabine 125mg/M2 as Conditioning for Elderly Patients With Hematological Malignancies in Unrelated Bone Marrow Transplantation Is Comparable in Safety and Effectiveness With TBI/Cy for Younger Patients
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
A Case of Transverse Colon Actinomycosis.
Nippon Daicho Komonbyo Gakkai Zasshi
Related publications
I.v. BU/fludarabine Plus Melphalan or TBI in Unrelated Cord Blood Transplantation for High-Risk Hematological Diseases
Bone Marrow Transplantation
Transplantation
Hematology
Fludarabine and 2-Gy TBI Is Superior to 2 Gy TBI as Conditioning for HLA-Matched Related Hematopoietic Cell Transplantation: A Phase III Randomized Trial
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Reduced-Toxicity Myeloablative Conditioning Consisting of Fludarabine/Busulfan/Low-Dose TBI/G-CSF-combined Cytarabine in Single Cord Blood Transplantation for Elderly Patients With Non-Remission Myeloid Malignancies
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Matched Unrelated Bone Marrow Transplantation With Reduced-Intensity Conditioning for Leukocyte Adhesion Deficiency
Bone Marrow Transplantation
Transplantation
Hematology
Transplant Conditioning With Treosulfan/Fludarabine With or Without TBI. A Randomized Phase II Trial in Patients With MDS and AML
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Reduced-Intensity Conditioning With Busulfan, Fludarabine, and Antithymocyte Globulin for Hematopoietic Cell Transplantation From Unrelated or Haploidentical Family Donors in Patients With Acute Myeloid Leukemia in Remission
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Dose-Dependent Effects of in Vivo Antithymocyte Globulin During Conditioning for Allogeneic Bone Marrow Transplantation From Unrelated Donors in Patients With Chronic Phase CML
Bone Marrow Transplantation
Transplantation
Hematology
Treatment of Hematological Malignancies With Nonmyeloablative, HLA-haploidentical Bone Marrow Transplantation and High Dose, Post-Transplantation Cyclophosphamide
Best Practice and Research in Clinical Haematology
Oncology
Clinical Biochemistry
Busulfan, Fludarabine, and Alemtuzumab Conditioning and Unrelated Cord Blood Transplantation in Children With Sickle Cell Disease
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
